Evidence map›Paper›PMID 40862223›Full record

ArticleHemaSphere2025

Preliminary evidence of CAR T-cell therapy activity in vitreoretinal lymphomas: An LOC network study.

Cécile Pivert, Adélaïde Toutée, Christophe Parizot, Denis Malaise, Alexandre Matet, Valérie Touitou, Magali Le Garff-Tavernier, Damien Roos-Weil, Sarah Touhami, Nabih Azar and 14 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Cécile PivertDepartment of Clinical Haematology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Adélaïde ToutéeDepartment of Ophthalmology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Christophe ParizotDepartment of Immunology, INSERM U1135, Center for Immunology and Infectious Diseases (CIMI), AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Denis MalaiseDepartment of Ophthalmology, Institut Curie Université Paris Cité Paris France.
Alexandre MatetDepartment of Ophthalmology, Institut Curie Université Paris Cité Paris France.
Valérie TouitouDepartment of Ophthalmology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Magali Le Garff-TavernierDepartment of Biological Haematology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Damien Roos-WeilDepartment of Clinical Haematology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Sarah TouhamiDepartment of Ophthalmology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Nabih AzarDepartment of Hemobiotherapy, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Ines BoussenDepartment of Clinical Haematology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Véronique MorelDepartment of Clinical Haematology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Madalina UzunovDepartment of Clinical Haematology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Clotilde BravettiDepartment of Biological Haematology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Carole MetzUnité REQPHARM, Pharmacie à Usage Intérieur, AP-HP, Pitié-Salpêtrière Hospital Sorbonne Université Paris France.
Eve TodescoDepatment of Virology, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Delphine SterlinDepartment of Immunology, INSERM U1135, Center for Immunology and Infectious Diseases (CIMI), AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Carole SoussainDepartment of Clinical Haematology Institut Curie St-Cloud France.
Kahina Ouis TarhiDepartment of Clinical Haematology Hôpital Nord-Ouest Val d'Oise, Site de Pontoise Pontoise France.
Anne BesançonDepartment of Clinical Haematology Centre Hospitalier Le Mans Le Mans France.
Khê Hoang-XuanDepartment of Neurology 2-Mazarin, INSERM, CNRS, Brain and Spine Institute, ICM, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Sylvain ChoquetDepartment of Clinical Haematology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Caroline HouillierDepartment of Neurology 2-Mazarin, INSERM, CNRS, Brain and Spine Institute, ICM, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.
Marine BaronDepartment of Clinical Haematology, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France.ORCID https://orcid.org/0000-0003-0212-8684

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40862223
PMCPMC12375968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.